chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Myalgia, Vaccination site pain
Clinical narrative: 15hrs post injection, muscle aches, joint pain; 15hrs post injection, muscle aches, joint pain; injection site pain 12hrs post injection; intense chills/shivering 12hrs post injection #2; This is a spontaneous report from a contactable nurse.  A 41-year-old non-pregnant female patient received the second dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EL3248 and Expiration Date: Apr2021), via an unspecified route of administration in the left arm on 15Jan2021 at 12:00 at 41-years-old at a single dose for COVID-19 immunization in a hospital.  Medical history included asthma from an unknown date and unknown if ongoing, gastrooesophageal reflux disease (GERD) from an unknown date and unknown if ongoing, thoracic outlet syndrome (arterial/neurogenic) from an unknown date and unknown if ongoing, Allergies to Iodine based contrast from an unknown date and unknown if ongoing, sulfonamide allergy from an unknown date and unknown if ongoing. The patient previously received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) for COVID-19 immunization on 28Dec2020 at 12:00 at 41-years-old and experienced no symptoms (first dose; Lot number: EJ1685, EXP: Mar2021, vaccine location: left arm). Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), levocetirizine dihydrochloride (XYZAL), omeprazole (PROTONIX); all taken for an unspecified indication from an unspecified date to an unspecified date; within two weeks of vaccination.  On 16Jan2021 at 00:00, the patient experienced: injection site pain 12hrs post injection, intense chills/shivering 12hrs post injection #2. On 16Jan2021 at 03:00, the patient experienced: 15hrs post injection, muscle aches, joint pain. Therapeutic measures were taken as a result of intense chills/shivering 12hrs post injection #2: relieved by 500 mg of paracetamol (TYLENOL) upon onset of chills (as reported). The clinical outcome of the events was recovering (as reported). The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site bruising
Clinical narrative: Bruising from injection site up to shoulder; This is a spontaneous report from a contactable healthcare professional (reporting for himself).  A 55-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EL3246), via an unspecified route of administration in the left arm on 09Jan2021 14:45 at a single dose for COVID-19 immunization.  Medical history included multiple sclerosis (MS).  Concomitant medication included lisinopril (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  The patient experienced bruising from injection site up to shoulder on 10Jan2021.  The patient did not received treatment for the event.  The outcome of bruising from injection site up to shoulder was not recovered.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: about 30-45 minutes later started feeling numbness on left side of face; left lower lip remained slightly numb; This is a spontaneous report from a contactable nurse. A 61-year-old female nurse reported that she received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EJ1686), intramuscular at single dose into the left arm on 08Jan2021 at 03:30 PM for COVID-19 immunization. First dose of BNT162B2 was received on 18Dec2020. Medical history included rheumatoid arthritis, coronary artery disease and hypertension.  Past drug history included NSAIDS which caused bleeding. The patient's concomitant medications were not reported.  The patient reported that about 30-45 minutes after vaccination she started feeling numbness on left side of face and left lower lip remained slightly numb. The events were reported as non-serious. The patient did not receive any treatment for the events. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was not recovered.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Headache, Pain, Pain in extremity
Clinical narrative: Sore L arm; body aches; chills; diarrhea; headache; This is a spontaneous report from a contactable physician (patient). A 45-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EL8982, expiration date unspecified), intramuscular on 14Jan2021 15:30 at single dose (left arm) for Covid-19 immunization. Medical history included vitamin d deficiency (def), Beta Thalassemia, some shellfish allergy, Sulfa allergy and COVID-19, which was prior to vaccination. Concomitant medication included vitamin D3. The patient received vitamin D3 within 2 weeks of vaccination. On 15Jan2021 at 06:45, the patient experienced sore left (L) arm, body aches, chills, diarrhea, and headache. The patient did not received treatment for the events. Facility where the most recent COVID-19 vaccine was administered was at the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and patient had not been tested for Covid-19 since the vaccination. Outcome of events was recovering.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Vaccination site pain
Clinical narrative: some injection site tenderness; a really bad head ache; fatigue; joint pain; This is a spontaneous report from a contactable consumer (patient). A 71-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on 12Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient received his first dose 4 days ago and reported some injection site tenderness on 12Jan2021.  He stated that 18 hours after his injection he had "a really bad head ache", fatigue, and joint pain for the remainder of the day on Jan2021. Outcome of the events was recovered on Jan2021.  Information on the lot/batch number has been requested.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Agitation, Balance disorder, Dizziness, Headache, Pain
Clinical narrative: Headache; body aches; fever; dizziness; sore arm; drowsiness; loss of balance; agitation; skin ach; This is a spontaneous report from a contactable consumer (patient). A 49-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231 and expiration date not provided), via an unspecified route of administration in the left arm on 15Jan2021 13:30 at a single dose for COVID-19 immunization. Medical history included osteoarthritis, guttate psoriasis, degenerative disc disease, fibromyalgia, COVID, and allergies (unspecified). The patient did not receive any other vaccine in 4 weeks. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medication included unspecified medication. The patient experienced headache, body aches, fever, dizziness, sore arm, drowsiness, loss of balance, agitation, and "skin ach" on 15Jan2021 21:00. Treatment was not provided in response to the events. The patient has not undergone COVID test post vaccination. The outcome of the events was recovered with sequel on an unspecified date in Jan2021.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pain of skin, Pyrexia, Somnolence
Clinical narrative: Headache; body aches; fever; dizziness; sore arm; drowsiness; loss of balance; agitation; skin ach; This is a spontaneous report from a contactable consumer (patient). A 49-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231 and expiration date not provided), via an unspecified route of administration in the left arm on 15Jan2021 13:30 at a single dose for COVID-19 immunization. Medical history included osteoarthritis, guttate psoriasis, degenerative disc disease, fibromyalgia, COVID, and allergies (unspecified). The patient did not receive any other vaccine in 4 weeks. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medication included unspecified medication. The patient experienced headache, body aches, fever, dizziness, sore arm, drowsiness, loss of balance, agitation, and "skin ach" on 15Jan2021 21:00. Treatment was not provided in response to the events. The patient has not undergone COVID test post vaccination. The outcome of the events was recovered with sequel on an unspecified date in Jan2021.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Crying, Fatigue, Gait disturbance, Loss of personal independence in daily activities
Clinical narrative: muscles hurt so bad/severe myalgias, muscle aches; couldn't walk; sobbing; pain; fiance had to change her clothes for her; bad oral herpes outbreak; joint pains; malaise; fatigue; This is a spontaneous report from a contactable Physician reported for herself. A 32-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number Eh9899 and expiry date unknown) intramuscular at the left arm on 29Dec2020 09:00 at single dose for Covid-19 immunization in a hospital. Medical history included endometriosis. The patient has no Covid prior vaccination. The patient was not pregnant. Concomitant medications included norethindrone [norethisterone], lifitegrast (XIIDRA), dextromethorphan hydrobromide, guaifenesin, paracetamol, pseudoephedrine hydrochloride (DAYQUIL); all from unspecified date for unspecified indication. The patient informed that the first 24 hours were so severe she almost went to the emergency department. On 12Dec2020: 20:00, her muscles hurt so bad she couldn't walk. The patient was sobbing in pain. Her fiance had to change her clothes for her. The patient got a bad oral herpes outbreak at about 24 hours of vaccination. The patient informed that she got better from this acute phase, however now at 3 weeks out she continued to struggle with joint pains, severe myalgias, muscle aches, malaise and fatigue that was worse with attempted exercise. The patient underwent lab test and procedures which included Covid test/blood test/antibodies: negative on 11Jan2021. The patient was Covid tested post vaccination. The patient did not received treatment due to the events.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Oral herpes, Pain, SARS-CoV-2 antibody test
Clinical narrative: muscles hurt so bad/severe myalgias, muscle aches; couldn't walk; sobbing; pain; fiance had to change her clothes for her; bad oral herpes outbreak; joint pains; malaise; fatigue; This is a spontaneous report from a contactable Physician reported for herself. A 32-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number Eh9899 and expiry date unknown) intramuscular at the left arm on 29Dec2020 09:00 at single dose for Covid-19 immunization in a hospital. Medical history included endometriosis. The patient has no Covid prior vaccination. The patient was not pregnant. Concomitant medications included norethindrone [norethisterone], lifitegrast (XIIDRA), dextromethorphan hydrobromide, guaifenesin, paracetamol, pseudoephedrine hydrochloride (DAYQUIL); all from unspecified date for unspecified indication. The patient informed that the first 24 hours were so severe she almost went to the emergency department. On 12Dec2020: 20:00, her muscles hurt so bad she couldn't walk. The patient was sobbing in pain. Her fiance had to change her clothes for her. The patient got a bad oral herpes outbreak at about 24 hours of vaccination. The patient informed that she got better from this acute phase, however now at 3 weeks out she continued to struggle with joint pains, severe myalgias, muscle aches, malaise and fatigue that was worse with attempted exercise. The patient underwent lab test and procedures which included Covid test/blood test/antibodies: negative on 11Jan2021. The patient was Covid tested post vaccination. The patient did not received treatment due to the events.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: muscles hurt so bad/severe myalgias, muscle aches; couldn't walk; sobbing; pain; fiance had to change her clothes for her; bad oral herpes outbreak; joint pains; malaise; fatigue; This is a spontaneous report from a contactable Physician reported for herself. A 32-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number Eh9899 and expiry date unknown) intramuscular at the left arm on 29Dec2020 09:00 at single dose for Covid-19 immunization in a hospital. Medical history included endometriosis. The patient has no Covid prior vaccination. The patient was not pregnant. Concomitant medications included norethindrone [norethisterone], lifitegrast (XIIDRA), dextromethorphan hydrobromide, guaifenesin, paracetamol, pseudoephedrine hydrochloride (DAYQUIL); all from unspecified date for unspecified indication. The patient informed that the first 24 hours were so severe she almost went to the emergency department. On 12Dec2020: 20:00, her muscles hurt so bad she couldn't walk. The patient was sobbing in pain. Her fiance had to change her clothes for her. The patient got a bad oral herpes outbreak at about 24 hours of vaccination. The patient informed that she got better from this acute phase, however now at 3 weeks out she continued to struggle with joint pains, severe myalgias, muscle aches, malaise and fatigue that was worse with attempted exercise. The patient underwent lab test and procedures which included Covid test/blood test/antibodies: negative on 11Jan2021. The patient was Covid tested post vaccination. The patient did not received treatment due to the events.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Epistaxis, Headache, Hypertension
Clinical narrative: hypertension; 1 nosebleed; slight headache; This is a spontaneous report from a contactable nurse. A 32-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot EL0140, expiry date not reported), via an unspecified route of administration on 09Jan2021 09:45 at a single dose in the right arm for COVID-19 immunization. Medical history included known allergies on penicillin as child. The patient had no COVID prior to vaccination. The patient's concomitant medications were not reported. Patient had the first dose of BNT162B2 (Pfizer brand, Lot number: EH9899) on 21Dec2020 08:45 AM in the left arm for COVID-19 immunization. The patient had no other vaccine in four weeks. Patient received second dose 09Jan2021 and for the last 4 days, started on 12Jan2021, the have had hypertension with 1 nosebleed and slight headache with no history of hypertension. No treatments received in response to the events reported. The patient was not tested for COVID post vaccination. The outcome of the events hypertension, nosebleed and slight headache was not recovered.
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis, Fatigue, Haemoptysis, Headache, Malaise
Clinical narrative: Tiredness; Headache; Nausea; Swelling; Feeling unwell; Nose bleed; Coughed up a blood clot; Congestion; This is a spontaneous report from a contactable consumer (patient).  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient experienced tiredness, headache, nausea, swelling, feeling unwell, nose bleed, coughed up a blood clot and congestion on an unspecified date.  The patient underwent lab tests and procedures which included sars-cov-2 test: unknown results   on   COVID test close to that time too where they swabbed my nose. Details were as follows: patient got the vaccine on 19th (month and year unspecified), and the COVID test with unknown results close to that  time, where they swabbed her nose. She has had  had tiredness, headache, nausea, swelling, feeling unwell, and the last night she had a nose bleed and coughed up a blood clot out of her throat. She also  had a lot of congestion since taking the injection, and did not know if it was from the injection or the COVID Test. The outcome of tiredness, headache, nausea, swelling, feeling unwell, nose bleed, coughed up a blood clot and congestion was unknown.   The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Nausea, SARS-CoV-2 test, Swelling
Clinical narrative: Tiredness; Headache; Nausea; Swelling; Feeling unwell; Nose bleed; Coughed up a blood clot; Congestion; This is a spontaneous report from a contactable consumer (patient).  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient experienced tiredness, headache, nausea, swelling, feeling unwell, nose bleed, coughed up a blood clot and congestion on an unspecified date.  The patient underwent lab tests and procedures which included sars-cov-2 test: unknown results   on   COVID test close to that time too where they swabbed my nose. Details were as follows: patient got the vaccine on 19th (month and year unspecified), and the COVID test with unknown results close to that  time, where they swabbed her nose. She has had  had tiredness, headache, nausea, swelling, feeling unwell, and the last night she had a nose bleed and coughed up a blood clot out of her throat. She also  had a lot of congestion since taking the injection, and did not know if it was from the injection or the COVID Test. The outcome of tiredness, headache, nausea, swelling, feeling unwell, nose bleed, coughed up a blood clot and congestion was unknown.   The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Pyrexia
Clinical narrative: Fever 102; chills; headache; joint pain; fatigue; This is a spontaneous report from a contactable other healthcare professional (patient). A 50-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EL1284, expiration date not reported) via an unspecified route of administration on the left arm on 11Jan2021 11:00 at a single dose for COVID-19 immunization. The patient had no medical history. The patient's concomitant medications were not reported. The patient previously received 1st dose of BNT162B2 on 21Dec2020 for COVID-19 immunization. On 11Jan2021 at 09:00 PM, the patient experienced fever 102, chills, headache, joint pain, and fatigue for 2 days. No treatment was received for the events. The facility where the vaccine was administered was in a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There were no other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. No known allergies. Outcome of the events was recovered in Jan2021.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discomfort, Vaccination site pain
Clinical narrative: slight discomfort at the site of injection; occasional soreness at the site of injection; This is a spontaneous report from a contactable physician reporting for herself. A 76-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), intramuscular in left arm on 22Dec2020 12:00 at single dose for COVID-19 immunization. Medical history included high cholesterol from an unknown date and unknown if ongoing. Concomitant medication included atorvastatin, calcium, ibuprofen, estrogens conjugated (PREMARIN), ergocalciferol (VIT D) and multivit (as reported). The patient was not pregnant. For vaccine dose 1, it was reported that the patient experienced slight discomfort at the site of injection and occasional soreness at the site of injection over on 22Dec2020. No treatment was given to the patient for the events. The outcome of the events was recovered on unspecified date. The facility where the most recent COVID-19 vaccine was administered was in the Health Clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Nausea, Pain in extremity
Clinical narrative: Fever 101; pain in both thigh; chills; nausea; headache; This is a spontaneous report from a contactable nurse (patient herself). A 61-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140, expiry date not reported), via an unspecified route of administration in the left arm on 13Jan2021 13:00 at single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS). Concomitant medications were none. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was vaccinated at a hospital. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient had no allergies to medications, food, or other products. On 14Jan2021 01:00, the patient experienced fever 101, pain in both thighs, chills, nausea and headache. No treatment was received for the adverse events. Clinical outcome of the events was recovered with sequelae on Jan2021.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever 101; pain in both thigh; chills; nausea; headache; This is a spontaneous report from a contactable nurse (patient herself). A 61-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140, expiry date not reported), via an unspecified route of administration in the left arm on 13Jan2021 13:00 at single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS). Concomitant medications were none. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was vaccinated at a hospital. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient had no allergies to medications, food, or other products. On 14Jan2021 01:00, the patient experienced fever 101, pain in both thighs, chills, nausea and headache. No treatment was received for the adverse events. Clinical outcome of the events was recovered with sequelae on Jan2021.
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: swollen lymph nodes; lymph nodes were swollen, it was very painful; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was reporting swollen lymph nodes following administration of the second dose of the Pfizer-Biontech Covid19 vaccine. Her lymph nodes were swollen, it was very painful. It was near her collar bone, near her shoulder. She never had this before, so she was asking for some advice. Outcome of the events was unknown.  Information on the Lot/batch number has been requested.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Very light soreness at injection site; This is a spontaneous report from a contactable consumer. A 73-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: E13248), via an unspecified route of administration from 16Jan2021 at 09:15 on his right arm at a single dose for COVID-19 immunization. Medical history included hypertension (successfully controlled with 10 mg lisinopril) from an unknown date and unknown if ongoing. Concomitant medications included fish oil, glucosamine and lisinopril. The patient experienced very light soreness at injection site on 16Jan2021 at 10:00. The patient did not receive treatment for the event. The outcome of the event was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on both arms and stomach; This is a spontaneous report from a contactable other healthcare professional (HCP) (patient). A 68-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0142, expiration date: unknown), intramuscular (left arm) on 13Jan2021 at 01:45 at a single dose for COVID-19 immunization. Medical history included known allergies. The patient is not pregnant. Concomitant medications were not reported. The patient had no other vaccine in four weeks. The patient had no COVID prior vaccination and had not tested post-vaccination. The patient experienced rash on both arms and stomach on 16Jan2021 at 09:30. No treatment administered for the event. The event had not resolved.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes in left armpit; This is a spontaneous report from a contactable consumer (patient).  A 29-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number: ELI283, via an unspecified route of administration on Left Arm from 07Jan2021 14:45 to 07Jan2021 14:45 as SINGLE DOSE for COVID-19 immunisation.  Medical history included none.  The patient's concomitant medications were not reported.  The patient experienced Swollen lymph nodes in left armpit on 08Jan2021 12:00 with outcome of not recovered. The patient is not pregnant. Patient was not tested for COVID prior and post vaccination.  No treatment was received for the event.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lymphadenopathy, Myalgia, Pyrexia
Clinical narrative: Fever; chills; myalgia; large left axillary lymphadenopathy; This is a spontaneous report from a contactable physician (patient).  A 32-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number EJ1686), intramuscular at left arm on 14Jan2021 12:00 at single dose for COVID-19 immunization at a hospital. There was no known allergies, no other medical history. There were no concomitant medications, the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not receive any other medications within 2 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number EJ1685), intramuscular at left arm on 23Dec2020 12:00 for COVID-19 immunization at a hospital. The patient had no COVID prior to vaccination, and had not been tested for COVID since the vaccination. It was reported that on 16Jan2021 01:00, the patient experienced fever, chills, myalgia and large left axillary lymphadenopathy. No treatment was received for the events. The outcome of the events was reported as "recovered with lasting effects".
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lymphadenopathy, Pain, Vaccination site pain
Clinical narrative: Swollen axillary lymph node on same side as injection; fatigue; body aches; headache; injection site soreness; This is a spontaneous report from a contactable nurse. A 49-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3302), via an unspecified route of administration in left arm on 13Jan2021 00:15 at a single dose for COVID-19 immunization. Vaccination was done in a hospital. Medical history included asthma, anxiety and penicillin allergy. The patient did not have COVID prior to vaccination. Concomitant medication included escitalopram oxalate (LEXAPRO), cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), zinc (ZINC), vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]), and montelukast sodium (SINGULAIR). The patient previously received the first dose of bnt162b2 (lot number EL1284) on 23Dec2020 12:00 PM in left arm for COVID-19 immunization. The patient experienced swollen axillary lymph node on same side as injection, fatigue, body aches, headache, injection site soreness on 13Jan2021 20:00. The outcome of the events was recovering. No treatment was received for the events. The patient was not tested for COVID-19 post vaccination.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: Injection site pain; Body aches; This is a spontaneous report from a contactable nurse (reporting for self).  A 37-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE),  lot number EL1283, intramuscularly on 09Jan2021 as a single dose (Dose 2), for COVID-19 immunization.  Medical history included depression. The patient had not experienced COVD prior to vaccination. The patient had no known allergies.  Concomitant medication included bupropion hydrochloride (WELLBUTRIN).  The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number EK5730 as a single dose (Dose 1) on 09Jan202110:00 right arm, for COVID-19 immunization. There was no other vaccine administered in the 4 weeks prior to the COVI-19 vaccination. There was no reaction with the 1st dose. With the 2nd dose, the patient experienced injection site pain and body aches for 24 hours, onset Jan2021. There was no treatment received for the event. The outcome of the events injection site pain and body aches was recovered in Jan2021.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, SARS-CoV-2 test
Clinical narrative: Left side lymph node supraclavicular swollen; This is a spontaneous report from a contactable consumer (patient). A 38-year-old female patient (non-pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EH9899), via an unspecified route of administration in left arm, on 27Dec2020 at 11:00, at a single dose, for COVID-19 immunization. The patient's medical history included irritable bowel syndrome (IBS), and human papilloma virus (HPV-16). The patient's concomitant medication included plecanatide (TRULANCE). The patient had no known allergies. The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. The vaccine was administered in a public health clinic or veteran's administration facility. On 01Jan2021 at 08:00 AM, the patient experienced left side lymph node supraclavicular swollen 5 days after the injection. The event resulted in doctor or other healthcare professional office or clinic visit. At the time of reporting, it is still enlarged. It was unknown if treatment was given for the event. The patient underwent COVID-19 oral swab test by curative post-vaccination on 09Jan2021 that was negative. The patient had not recovered from the event.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Numbness of pinky and ring finger; This is a spontaneous report from a contactable other healthcare professional (patient).  A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number not reported, via an unspecified route of administration from 15Jan2021 06:30 to 15Jan2021 06:30 as SINGLE DOSE for COVID-19 immunisation.  The patient's medical history and concomitant medications were not reported.  The patient experienced numbness of pinky and ring finger on an unspecified date with outcome of unknown. Therapeutic measures were taken as a result of numbness of pinky and ring finger which includes prednisone. The patient is not pregnant. The patient was not tested with COVID prior and post vaccination.  Information on the Batch/Lot number has been requested.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Myalgia
Clinical narrative: Headache; moderate joint and muscle pain; muscle pain; This is a spontaneous report from a contactable other healthcare professional (HCP) reporting for herself. A 51-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at left arm on 14Jan2021 12:45 at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Clinic/Administration facility. Medical history included High blood pressure, fibromyalgia, psoriatic arthritis. Patient was not pregnant. Concomitant medications included lisinopril, cyanocobalamin (B12), pyridoxine hydrochloride (B6) and Multivitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced Headache and moderate joint and muscle pain lasting 16-18 hours on 15Jan2021 06:00, treated with 800 mg ibuprofen every 4-6 hours. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was recovered on 15Jan2021.   Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Nasal congestion, Throat irritation
Clinical narrative: severe allergies; Stuffed up nose; scratchy throat; This is a spontaneous report from a contactable consumer reported that a female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient had the first dose and had severe allergies. She had three different reactions since the shot, stuffed up nose and scratchy throat. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Lymphadenopathy, Malaise
Clinical narrative: Headache; Fatigued; Swollen Lymph Nodes; Chills; Nausea; Feeling Unwell; Body Aches; This is a spontaneous report from a contactable consumer (patient himself). An adult male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number EL8982), via an unspecified route of administration (right arm), on 14Jan2021, at single dose, for covid-19 immunization. Medical history included hypertension. The patient's concomitant medications were not reported. The patient experienced headache, fatigued, swollen lymph nodes, chills, nausea, feeling unwell, and body aches - all on 14Jan2021. The patient had none of these symptoms prior to the shot. The patient had no Covid prior vaccination, had no other vaccine in four weeks, and had not been Covid-tested post vaccination. The patient was recovering from the events. No treatment was received for the events reported.
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain
Clinical narrative: Headache; Fatigued; Swollen Lymph Nodes; Chills; Nausea; Feeling Unwell; Body Aches; This is a spontaneous report from a contactable consumer (patient himself). An adult male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number EL8982), via an unspecified route of administration (right arm), on 14Jan2021, at single dose, for covid-19 immunization. Medical history included hypertension. The patient's concomitant medications were not reported. The patient experienced headache, fatigued, swollen lymph nodes, chills, nausea, feeling unwell, and body aches - all on 14Jan2021. The patient had none of these symptoms prior to the shot. The patient had no Covid prior vaccination, had no other vaccine in four weeks, and had not been Covid-tested post vaccination. The patient was recovering from the events. No treatment was received for the events reported.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes under both armpits; This is a spontaneous report from a contactable healthcare professional (patient). A 34-year-old female patient (non-pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EK9231), intramuscular in left arm, on 09Jan2021 at 10:30, at a single dose, for COVID-19 immunization. The patient's medical history was not reported. The patient's concomitant medications included ibuprofen and lorazepam. The patient previously took the first dose of BNT162B2 (Lot Number: EK5730) on 18Dec2020 at 06:30 PM (intramuscular in right arm) for COVID-19 immunization. The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. The vaccine was administered in a hospital facility. On 15Jan2021 at 12:00 AM, the patient experienced swollen lymph nodes under both armpits a week after administration of the vaccine. It was unknown if treatment was given for the adverse event. The patient has not been tested for COVID-19 post-vaccination. The patient was recovering from the event.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Headache - still continuing; Felt fever - like - for 3 days; This is a spontaneous report from a contactable consumer (patient). A 71-years-old female patient received BNT162B2 (lot number: EL3246) via an unspecified route of administration on 11Jan2021 10:00 at single dose for COVID-19 immunisation. Medical history included controlled diabetes. The patient was allergic to Penicillin. Concomitant medication included metformin, atorvastatin (LIPITOR), lisinopril, and Multivitamin. On 11Jan2021, the patient experienced headache - still continuing, this is the 5th day after the vaccination. On 11Jan2021, the patient also had felt fever - like - for 3 days. The patient received Advil as treatment. The patient is not pregnant. Events outcome was not recovered.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Rash
Clinical narrative: Rash on opposite chest and upper limb of injection; Behaves and looks like shingles; This is a spontaneous report from a contactable healthcare professional (patient). A 25-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), intramuscular on the left arm, on 13Jan2021 09:00 at a single dose for COVID-19 immunization. There were no medical history and concomitant medications. The patient experienced rash on opposite chest and upper limb of injection which behaves and looks like shingles but not officially diagnosed on 14Jan2021 12:00. Outcome of the events was not recovered. No treatment was received for the events. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.  Information about batch/lot number has been requested.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Nausea, Pain in extremity, Pyrexia
Clinical narrative: Fever; chills; nausea; vomiting; diarrhea; sore arm; This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249), via an unspecified route of administration at right arm on 15Jan2021 16:00 at single dose for COVID-19 immunization. Medical history included COVID prior to vaccination. The patient has no known allergies. The patient's concomitant medications were not reported. The patient experienced fever, chills, nausea, vomiting, diarrhea, and sore arm on 16Jan2021. No treatment was received for the events. The patient was not tested for COVID post vaccination. The patient was recovering from the events.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Fever; chills; nausea; vomiting; diarrhea; sore arm; This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249), via an unspecified route of administration at right arm on 15Jan2021 16:00 at single dose for COVID-19 immunization. Medical history included COVID prior to vaccination. The patient has no known allergies. The patient's concomitant medications were not reported. The patient experienced fever, chills, nausea, vomiting, diarrhea, and sore arm on 16Jan2021. No treatment was received for the events. The patient was not tested for COVID post vaccination. The patient was recovering from the events.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, SARS-CoV-2 test
Clinical narrative: Dizziness and lightheadedness on day 3-5 after second dose.; This is a spontaneous report from a contactable nurse (patient). A 43-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number and expiration date: unknown), via an unspecified route of administration (right arm) on 11Jan2021 at 12:15 at a single dose for COVID-19 immunization. Medical history included COVID prior vaccination, known since 25Dec2020 and unknown if ongoing. The patient had no known allergies. The patient is not pregnant. There were no concomitant medications. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunization on an unspecified date. The patient had no other vaccine in four weeks and no other medications in two weeks. The patient experienced dizziness and lightheadedness on day 3-5 after the second dose on 14Jan2021 at 0900. No treatment administered for the event. The event was resolving.   Information about lot/batch number has been requested.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Headache, Nausea, Pain
Clinical narrative: headaches; achy feeling; nausea; felt hot; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot EL3249) via an unspecified route of administration in the left arm on 12Jan2021 09:15 AM at a single dose for COVID vaccine. Medical history included rheumatoid arthritis. Concomitant medications included leflunomide, paroxetine, and ergocalciferol (VITAMIN D) (other medications in two weeks). The patient had no other vaccine in four weeks. The patient had known allergies to sulfamethoxazole/trimethoprim (SEPTRA) and mefloquine. It was reported that the patient had 4 days of headaches and achy feeling on 12Jan2021. During her 30-minute wait after the injection, she experienced some nausea and felt hot on 12Jan2021. Treatment was not received for the events. The patient had no COVID prior vaccination. She did not have COVID tested post vaccination. The outcome of the events was recovering.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: The only thing I have with the first injection is soreness at injection site; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number: EL3248, via unspecified route of administration in the left arm on 15Jan2021 (15:30) at single dose for COVID-19 immunization. Patient medical history included high blood pressure (HBP). Concomitant medications included latanoprostene bunod (VYZULTA 0.024%), losartan at 25 mg, and oxybutynin (5 mg ER) for unspecified indications. Patient is not pregnant at the time of vaccination. The patient reported that the only adverse event she had after first injection was soreness at injection site on 15Jan2021 at 3:30 pm. No treatment was received for the event. Outcome of the event was recovered on unspecified date in Jan2021.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased, Product use issue
Clinical narrative: elevated heart rate at rest. It's usually 80-90 at rest and now it's 130 and it's been like this for 2 to 3 hours.; received other vaccine at first dose in right arm on the same date; This is a spontaneous report from a non-contactable consumer (patient). A 23-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, unknown lot number and expiration), via an unspecified route of administration in right arm on 15Jan2021 at 12:00 PM at a single dose for COVID-19 immunization.  Medical history reported as none.  The patient has no known allergies. The patient also received other vaccine at first dose in right arm on the same date. On 16Jan2021 at 05:00 PM (17:00), the patient experienced elevated heart rate at rest. It's usually 80-90 at rest and now it's 130 and it's been like this for 2 to 3 hours. The patient did not receive treatment for the event. The patient has no COVID prior to vaccination and was not tested for COVID post vaccination.  The patient had not yet recovered from the event elevated heart rate at rest.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Peripheral swelling
Clinical narrative: Sore arm; swelling in arm; fatigue; This is a spontaneous report from a contactable consumer (patient). An 87-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EL0142), via an unspecified route of administration on 13Jan2021 12:30 PM at single dose on the right arm for COVID-19 immunization. Patient is not pregnant. Medical history included bad back and bad left knee. Concomitant medication included unspecified drug (reported as "Other medications in two weeks: Yes"). The patient previously took Levaquin and experienced allergies. Facility type vaccine was hospital. No other vaccines in four weeks. No COVID prior vaccination. The patient experienced sore arm, swelling in arm and fatigue for 24 hours after the shot on 13Jan2021 12:30 PM. Slowly dissipated over next 24 hours. All adverse events went away after 48 hours. No treatment for the events. Patient was not tested for COVID post vaccination. Outcome of the events was recovered on 15Jan2021 12:30.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Lip swelling, Swelling face
Clinical narrative: Diarrhea; Swelling on the lower Lip and left facial area; Swelling on the lower Lip and left facial area; This is a spontaneous report from a contactable consumer (patient). A 74-year-old male received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL1283 and expiry date: unknown), via an unspecified route of administration on the left arm, on 13Jan2021 16:30 at a single dose for COVID-19 immunization. Medical history included asthma, sinus and sensitive to egg white and milk. Concomitant medication included simvastatin, losartan and syzygium jambolanum. The patient experienced diarrhea, swelling on the lower lip and left facial area on 14Jan2021 09:00. Outcome of the events was recovering. No treatment was received for the events. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.